Literature DB >> 33643638

Mathematical modeling of the SARS-CoV-2 epidemic in Qatar and its impact on the national response to COVID-19.

Houssein H Ayoub1, Hiam Chemaitelly2,3, Shaheen Seedat2,3,4, Monia Makhoul2,3,4, Zaina Al Kanaani5, Abdullatif Al Khal5, Einas Al Kuwari5, Adeel A Butt4,5, Peter Coyle5, Andrew Jeremijenko5, Anvar Hassan Kaleeckal5, Ali Nizar Latif5, Riyazuddin Mohammad Shaik5, Hanan Abdul Rahim6, Hadi M Yassine7,8, Mohamed G Al Kuwari9, Hamad Eid Al Romaihi10, Mohamed H Al-Thani10, Roberto Bertollini10, Laith J Abu Raddad2,3,4.   

Abstract

BACKGROUND: Mathematical modeling constitutes an important tool for planning robust responses to epidemics. This study was conducted to guide the Qatari national response to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic. The study investigated the epidemic's time-course, forecasted health care needs, predicted the impact of social and physical distancing restrictions, and rationalized and justified easing of restrictions.
METHODS: An age-structured deterministic model was constructed to describe SARS-CoV-2 transmission dynamics and disease progression throughout the population.
RESULTS: The enforced social and physical distancing interventions flattened the epidemic curve, reducing the peaks for incidence, prevalence, acute-care hospitalization, and intensive care unit (ICU) hospitalizations by 87%, 86%, 76%, and 78%, respectively. The daily number of new infections was predicted to peak at 12 750 on May 23, and active-infection prevalence was predicted to peak at 3.2% on May 25. Daily acute-care and ICU-care hospital admissions and occupancy were forecast accurately and precisely. By October 15, 2020, the basic reproduction number R0 had varied between 1.07-2.78, and 50.8% of the population were estimated to have been infected (1.43 million infections). The proportion of actual infections diagnosed was estimated at 11.6%. Applying the concept of Rt tuning, gradual easing of restrictions was rationalized and justified to start on June 15, 2020, when Rt declined to 0.7, to buffer the increased interpersonal contact with easing of restrictions and to minimize the risk of a second wave. No second wave has materialized as of October 15, 2020, five months after the epidemic peak.
CONCLUSIONS: Use of modeling and forecasting to guide the national response proved to be a successful strategy, reducing the toll of the epidemic to a manageable level for the health care system.
Copyright © 2021 by the Journal of Global Health. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 33643638      PMCID: PMC7897910          DOI: 10.7189/jogh.11.05005

Source DB:  PubMed          Journal:  J Glob Health        ISSN: 2047-2978            Impact factor:   4.413


  19 in total

1.  Epidemic and intervention modelling--a scientific rationale for policy decisions? Lessons from the 2009 influenza pandemic.

Authors:  Maria D Van Kerkhove; Neil M Ferguson
Journal:  Bull World Health Organ       Date:  2012-04-01       Impact factor: 9.408

2.  Translation of Real-Time Infectious Disease Modeling into Routine Public Health Practice.

Authors:  David J Muscatello; Abrar A Chughtai; Anita Heywood; Lauren M Gardner; David J Heslop; C Raina MacIntyre
Journal:  Emerg Infect Dis       Date:  2017-05       Impact factor: 6.883

3.  Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome.

Authors:  Daniela Weiskopf; Katharina S Schmitz; Alessandro Sette; Rory D de Vries; Matthijs P Raadsen; Alba Grifoni; Nisreen M A Okba; Henrik Endeman; Johannes P C van den Akker; Richard Molenkamp; Marion P G Koopmans; Eric C M van Gorp; Bart L Haagmans; Rik L de Swart
Journal:  Sci Immunol       Date:  2020-06-26

Review 4.  Pre-existing immunity to SARS-CoV-2: the knowns and unknowns.

Authors:  Alessandro Sette; Shane Crotty
Journal:  Nat Rev Immunol       Date:  2020-08       Impact factor: 53.106

5.  Epidemiological investigation of the first 5685 cases of SARS-CoV-2 infection in Qatar, 28 February-18 April 2020.

Authors:  Hanan M Al Kuwari; Hanan F Abdul Rahim; Laith J Abu-Raddad; Abdul-Badi Abou-Samra; Zaina Al Kanaani; Abdullatif Al Khal; Einas Al Kuwari; Salih Al Marri; Muna Al Masalmani; Hamad E Al Romaihi; Mohamed H Al Thani; Peter V Coyle; Ali N Latif; Robert Owen; Roberto Bertollini; Adeel Ajwad Butt
Journal:  BMJ Open       Date:  2020-10-07       Impact factor: 2.692

6.  Epidemiological Impact of SARS-CoV-2 Vaccination: Mathematical Modeling Analyses.

Authors:  Monia Makhoul; Houssein H Ayoub; Hiam Chemaitelly; Shaheen Seedat; Ghina R Mumtaz; Sarah Al-Omari; Laith J Abu-Raddad
Journal:  Vaccines (Basel)       Date:  2020-11-09

7.  Assessment of the risk of SARS-CoV-2 reinfection in an intense re-exposure setting.

Authors:  Laith J Abu-Raddad; Hiam Chemaitelly; Joel A Malek; Ayeda A Ahmed; Yasmin A Mohamoud; Shameem Younuskunju; Houssein H Ayoub; Zaina Al Kanaani; Abdullatif Al Khal; Einas Al Kuwari; Adeel A Butt; Peter Coyle; Andrew Jeremijenko; Anvar Hassan Kaleeckal; Ali Nizar Latif; Riyazuddin Mohammad Shaik; Hanan F Abdul Rahim; Hadi M Yassine; Mohamed G Al Kuwari; Hamad Eid Al Romaihi; Mohamed H Al-Thani; Roberto Bertollini
Journal:  Clin Infect Dis       Date:  2020-12-14       Impact factor: 9.079

8.  Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study.

Authors:  Silvia Stringhini; Ania Wisniak; Giovanni Piumatti; Andrew S Azman; Stephen A Lauer; Hélène Baysson; David De Ridder; Dusan Petrovic; Stephanie Schrempft; Kailing Marcus; Sabine Yerly; Isabelle Arm Vernez; Olivia Keiser; Samia Hurst; Klara M Posfay-Barbe; Didier Trono; Didier Pittet; Laurent Gétaz; François Chappuis; Isabella Eckerle; Nicolas Vuilleumier; Benjamin Meyer; Antoine Flahault; Laurent Kaiser; Idris Guessous
Journal:  Lancet       Date:  2020-06-11       Impact factor: 79.321

9.  Age could be driving variable SARS-CoV-2 epidemic trajectories worldwide.

Authors:  Houssein H Ayoub; Hiam Chemaitelly; Shaheen Seedat; Ghina R Mumtaz; Monia Makhoul; Laith J Abu-Raddad
Journal:  PLoS One       Date:  2020-08-20       Impact factor: 3.240

10.  Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals.

Authors:  Alba Grifoni; Daniela Weiskopf; Sydney I Ramirez; Jose Mateus; Jennifer M Dan; Carolyn Rydyznski Moderbacher; Stephen A Rawlings; Aaron Sutherland; Lakshmanane Premkumar; Ramesh S Jadi; Daniel Marrama; Aravinda M de Silva; April Frazier; Aaron F Carlin; Jason A Greenbaum; Bjoern Peters; Florian Krammer; Davey M Smith; Shane Crotty; Alessandro Sette
Journal:  Cell       Date:  2020-05-20       Impact factor: 66.850

View more
  20 in total

1.  Association of Prior SARS-CoV-2 Infection With Risk of Breakthrough Infection Following mRNA Vaccination in Qatar.

Authors:  Laith J Abu-Raddad; Hiam Chemaitelly; Houssein H Ayoub; Hadi M Yassine; Fatiha M Benslimane; Hebah A Al Khatib; Patrick Tang; Mohammad R Hasan; Peter Coyle; Zaina Al Kanaani; Einas Al Kuwari; Andrew Jeremijenko; Anvar Hassan Kaleeckal; Ali Nizar Latif; Riyazuddin Mohammad Shaik; Hanan F Abdul Rahim; Gheyath K Nasrallah; Mohamed Ghaith Al Kuwari; Adeel A Butt; Hamad Eid Al Romaihi; Mohamed H Al-Thani; Abdullatif Al Khal; Roberto Bertollini
Journal:  JAMA       Date:  2021-11-16       Impact factor: 56.272

Review 2.  Biological Properties of SARS-CoV-2 Variants: Epidemiological Impact and Clinical Consequences.

Authors:  Reem Hoteit; Hadi M Yassine
Journal:  Vaccines (Basel)       Date:  2022-06-09

3.  COVID-19 risk score as a public health tool to guide targeted testing: A demonstration study in Qatar.

Authors:  Laith J Abu-Raddad; Soha Dargham; Hiam Chemaitelly; Peter Coyle; Zaina Al Kanaani; Einas Al Kuwari; Adeel A Butt; Andrew Jeremijenko; Anvar Hassan Kaleeckal; Ali Nizar Latif; Riyazuddin Mohammad Shaik; Hanan F Abdul Rahim; Gheyath K Nasrallah; Hadi M Yassine; Mohamed G Al Kuwari; Hamad Eid Al Romaihi; Mohamed H Al-Thani; Abdullatif Al Khal; Roberto Bertollini
Journal:  PLoS One       Date:  2022-07-19       Impact factor: 3.752

4.  Application of human RNase P normalization for the realistic estimation of SARS-CoV-2 viral load in wastewater: A perspective from Qatar wastewater surveillance.

Authors:  Shimaa S El-Malah; Jayaprakash Saththasivam; Khadeeja Abdul Jabbar; Arun K K; Tricia A Gomez; Ayeda A Ahmed; Yasmin A Mohamoud; Joel A Malek; Laith J Abu Raddad; Hussein A Abu Halaweh; Roberto Bertollini; Jenny Lawler; Khaled A Mahmoud
Journal:  Environ Technol Innov       Date:  2022-06-22

5.  SARS-CoV-2 Infection Is at Herd Immunity in the Majority Segment of the Population of Qatar.

Authors:  Mohamed H Al-Thani; Elmoubasher Farag; Roberto Bertollini; Hamad Eid Al Romaihi; Sami Abdeen; Ashraf Abdelkarim; Faisal Daraan; Ahmed Ibrahim Hashim Elhaj Ismail; Nahid Mostafa; Mohamed Sahl; Jinan Suliman; Elias Tayar; Hasan Ali Kasem; Meynard J A Agsalog; Bassam K Akkarathodiyil; Ayat A Alkhalaf; Mohamed Morhaf M H Alakshar; Abdulsalam Ali A H Al-Qahtani; Monther H A Al-Shedifat; Anas Ansari; Ahmad Ali Ataalla; Sandeep Chougule; Abhilash K K V Gopinathan; Feroz J Poolakundan; Sanjay U Ranbhise; Saed M A Saefan; Mohamed M Thaivalappil; Abubacker S Thoyalil; Inayath M Umar; Zaina Al Kanaani; Abdullatif Al Khal; Einas Al Kuwari; Adeel A Butt; Peter Coyle; Andrew Jeremijenko; Anvar Hassan Kaleeckal; Ali Nizar Latif; Riyazuddin Mohammad Shaik; Hanan F Abdul Rahim; Hadi M Yassine; Gheyath K Nasrallah; Mohamed Ghaith Al Kuwari; Odette Chaghoury; Hiam Chemaitelly; Laith J Abu-Raddad
Journal:  Open Forum Infect Dis       Date:  2021-05-02       Impact factor: 3.835

6.  SARS-CoV-2 antibody-positivity protects against reinfection for at least seven months with 95% efficacy.

Authors:  Laith J Abu-Raddad; Hiam Chemaitelly; Peter Coyle; Joel A Malek; Ayeda A Ahmed; Yasmin A Mohamoud; Shameem Younuskunju; Houssein H Ayoub; Zaina Al Kanaani; Einas Al Kuwari; Adeel A Butt; Andrew Jeremijenko; Anvar Hassan Kaleeckal; Ali Nizar Latif; Riyazuddin Mohammad Shaik; Hanan F Abdul Rahim; Gheyath K Nasrallah; Hadi M Yassine; Mohamed Ghaith Al Kuwari; Hamad Eid Al Romaihi; Mohamed H Al-Thani; Abdullatif Al Khal; Roberto Bertollini
Journal:  EClinicalMedicine       Date:  2021-04-28

7.  Herd Immunity against Severe Acute Respiratory Syndrome Coronavirus 2 Infection in 10 Communities, Qatar.

Authors:  Andrew Jeremijenko; Hiam Chemaitelly; Houssein H Ayoub; Moza Alishaq; Abdul-Badi Abou-Samra; Jameela Ali A A Al Ajmi; Nasser Ali Asad Al Ansari; Zaina Al Kanaani; Abdullatif Al Khal; Einas Al Kuwari; Ahmed Al-Mohammed; Naema Hassan Abdulla Al Molawi; Huda Mohamad Al Naomi; Adeel A Butt; Peter Coyle; Reham Awni El Kahlout; Imtiaz Gillani; Anvar Hassan Kaleeckal; Naseer Ahmad Masoodi; Anil George Thomas; Hanaa Nafady-Hego; Ali Nizar Latif; Riyazuddin Mohammad Shaik; Nourah B M Younes; Hanan F Abdul Rahim; Hadi M Yassine; Mohamed G Al Kuwari; Hamad Eid Al Romaihi; Mohamed H Al-Thani; Roberto Bertollini; Laith J Abu-Raddad
Journal:  Emerg Infect Dis       Date:  2021-05       Impact factor: 6.883

8.  Characterizing the Qatar advanced-phase SARS-CoV-2 epidemic.

Authors:  Laith J Abu-Raddad; Hiam Chemaitelly; Houssein H Ayoub; Zaina Al Kanaani; Abdullatif Al Khal; Einas Al Kuwari; Adeel A Butt; Peter Coyle; Andrew Jeremijenko; Anvar Hassan Kaleeckal; Ali Nizar Latif; Robert C Owen; Hanan F Abdul Rahim; Samya A Al Abdulla; Mohamed G Al Kuwari; Mujeeb C Kandy; Hatoun Saeb; Shazia Nadeem N Ahmed; Hamad Eid Al Romaihi; Devendra Bansal; Louise Dalton; Mohamed H Al-Thani; Roberto Bertollini
Journal:  Sci Rep       Date:  2021-03-18       Impact factor: 4.379

9.  Introduction and expansion of the SARS-CoV-2 B.1.1.7 variant and reinfections in Qatar: A nationally representative cohort study.

Authors:  Laith J Abu-Raddad; Hiam Chemaitelly; Houssein H Ayoub; Peter Coyle; Joel A Malek; Ayeda A Ahmed; Yasmin A Mohamoud; Shameem Younuskunju; Patrick Tang; Zaina Al Kanaani; Einas Al Kuwari; Adeel A Butt; Andrew Jeremijenko; Anvar Hassan Kaleeckal; Ali Nizar Latif; Riyazuddin Mohammad Shaik; Hanan F Abdul Rahim; Gheyath K Nasrallah; Hadi M Yassine; Mohamed Ghaith Al Kuwari; Hamad Eid Al Romaihi; Mohamed H Al-Thani; Abdullatif Al Khal; Roberto Bertollini
Journal:  PLoS Med       Date:  2021-12-16       Impact factor: 11.069

10.  Epidemiological impact of prioritising SARS-CoV-2 vaccination by antibody status: mathematical modelling analyses.

Authors:  Houssein H Ayoub; Hiam Chemaitelly; Monia Makhoul; Zaina Al Kanaani; Einas Al Kuwari; Adeel A Butt; Peter Coyle; Andrew Jeremijenko; Anvar Hassan Kaleeckal; Ali Nizar Latif; Riyazuddin Mohammad Shaik; Hanan F Abdul Rahim; Gheyath K Nasrallah; Hadi M Yassine; Mohamed G Al Kuwari; Hamad Eid Al Romaihi; Mohamed H Al-Thani; Roberto Bertollini; Abdullatif Al Khal; Laith J Abu-Raddad
Journal:  BMJ Innov       Date:  2021-03-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.